FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

SigmaPharm Laboratories Sodium Phenylbutyrate Powder Recall

Sodium Phenylbutyrate Powder, 250 Grams, Rx Only, packaged in 500 cc HDPE bottles and 5…

SigmaPharm Laboratories LLC · Bensalem, PA

Risk level
Class II
Reported by FDA
Oct 6, 2021
Recall ID
D-0898-2021
Check your lot numberHow we source this data

Summary

SigmaPharm Laboratories recalled Sodium Phenylbutyrate Powder starting Sep 21, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0898-2021 on Oct 6, 2021. Reason: Failed Impurities/Degradation Specifications; Out of Specification impurity results obtained during routine testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications; Out of Specification impurity results obtained during routine testing.

Product description

Sodium Phenylbutyrate Powder, 250 Grams, Rx Only, packaged in 500 cc HDPE bottles and 53 mm CRC caps packed in a carton and then in case packs containing 2 bottles. Sigmapharm Laboratories, LLC, Bensalem, PA 19020, NDC 42794-086-14

Lot numbers, UPCs & expiration codes

Lots 2005401, 2005501, 2005601, 2005701, Exp FEB 2023; Lots 2101401, 2101501, Exp FEB-2024

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0898-2021
Classification
Class II
Status
Terminated
Recall initiated
Sep 21, 2021
FDA report date
Oct 6, 2021
Quantity
1192 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
SigmaPharm Laboratories LLC

Original FDA data

Every field from FDA enforcement report D-0898-2021, exactly as published.

Show all FDA fields
City
Bensalem
State
PA
Status
Terminated
Country
United States
Event ID
88736
Address
3375 Progress Dr
Code information
Lots 2005401, 2005501, 2005601, 2005701, Exp FEB 2023; Lots 2101401, 2101501, Exp FEB-2024
Postal code
19020-5801
Report date
Oct 6, 2021
Product type
Drugs
Recall number
D-0898-2021
Classification
Class II
Recalling firm
SigmaPharm Laboratories LLC
Product quantity
1192 bottles
Termination date
Sep 26, 2022
Reason for recall
Failed Impurities/Degradation Specifications; Out of Specification impurity results obtained during routine testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sodium Phenylbutyrate Powder, 250 Grams, Rx Only, packaged in 500 cc HDPE bottles and 53 mm CRC caps packed in a carton and then in case packs containing 2 bottles. Sigmapharm Laboratories, LLC, Bensalem, PA 19020, NDC 42794-086-14
Distribution pattern
Nationwide
Recall initiation date
Sep 21, 2021
Initial firm notification
Letter
Center classification date
Sep 30, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0898-2021, published Oct 6, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls